These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38614995)
1. Serum PM20D1 levels in patients with idiopathic pulmonary arterial hypertension and its clinical significance. Wang L; Liu J; Zhou L; Fu Q BMC Cardiovasc Disord; 2024 Apr; 24(1):207. PubMed ID: 38614995 [TBL] [Abstract][Full Text] [Related]
2. Plasma irisin levels are associated with hemodynamic and clinical outcome in idiopathic pulmonary arterial hypertension patients. Sun N; Chen Y; Fan Y; Chang J; Gao X; Zhao Y; Sun H; Wang Z; Gu X; Tian J; Wu B Intern Emerg Med; 2021 Apr; 16(3):625-632. PubMed ID: 32797373 [TBL] [Abstract][Full Text] [Related]
3. Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients. Radchenko GD; Zhyvylo IO; Titov EY; Sirenko YM Vasc Health Risk Manag; 2020; 16():29-39. PubMed ID: 32021226 [TBL] [Abstract][Full Text] [Related]
4. Association of Right Atrial Mechanics with Hemodynamics and Physical Capacity in Patients with Idiopathic Pulmonary Arterial Hypertension: Insight from a Single-Center Cohort in Northern Sweden. Saha SK; Söderberg S; Lindqvist P Echocardiography; 2016 Jan; 33(1):46-56. PubMed ID: 26096217 [TBL] [Abstract][Full Text] [Related]
5. Potential of C-X-C motif chemokine ligand 1/8/10/12 as diagnostic and prognostic biomarkers in idiopathic pulmonary arterial hypertension. Li Z; Jiang J; Gao S Clin Respir J; 2021 Dec; 15(12):1302-1309. PubMed ID: 34260815 [TBL] [Abstract][Full Text] [Related]
6. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024 [TBL] [Abstract][Full Text] [Related]
7. Increased serum PCSK9 in patients with idiopathic pulmonary arterial hypertension: insights from inflammatory cytokines. Zhong DX; Zhang Y; Jin Q; Zhang XC; Zhang F; Chen DD; Guan LH; Zhou DX; Ge JB Pulm Circ; 2021; 11(4):20458940211051292. PubMed ID: 34659741 [TBL] [Abstract][Full Text] [Related]
8. The effect of docosahexaenoic acid on predicting the survival of patients with idiopathic pulmonary arterial hypertension. Huai X; Sun Y; Sun X; Wu W; Wang L; Jiang R; Gong S; Li J; Miao Y; Yuan P; Zhao Q Ann Transl Med; 2021 Jun; 9(12):995. PubMed ID: 34277795 [TBL] [Abstract][Full Text] [Related]
9. Differential serum lipid distribution in IPAH and CHD-PAH patients. Chen J; Rathinasabapathy A; Luo J; Yang X; Luo P; Chen Y; Li Z; Li J Respir Med; 2022 Jan; 191():106711. PubMed ID: 34890866 [TBL] [Abstract][Full Text] [Related]
10. [End tidal PCO(2) for evaluation of severity of disease in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension]. Shi X; Yang GL; Chen Y; Guo J; Yang WL; Yuan P; Gong SG; Jiang R; Zhao QH; Wang L; He J; Chen TX; Liu JM Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):34-39. PubMed ID: 28100360 [No Abstract] [Full Text] [Related]
11. CTA-derived left to right atrial size ratio distinguishes between pulmonary hypertension due to heart failure and idiopathic pulmonary arterial hypertension. Huis In 't Veld AE; Van Vliet AG; Spruijt OA; Handoko ML; Marcus JT; Vonk Noordegraaf A; Bogaard HJ Int J Cardiol; 2016 Nov; 223():723-728. PubMed ID: 27573596 [TBL] [Abstract][Full Text] [Related]
12. Association of changes in NT-proBNP, hsTnT and uric acid levels with haemodynamic changes after targeted medical therapies in patients with idiopathic pulmonary arterial hypertension. Li WT; Wu CW; Liu JM Cardiovasc J Afr; 2022 Jan-Feb 23; 33(1):10-14. PubMed ID: 34851353 [TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Peptidase M20 Domain Containing 1 Ii Patients with Carotid Atherosclerosis. Huang X; He P; Wu L Arq Bras Cardiol; 2022 Sep; 119(3):372-379. PubMed ID: 35544855 [TBL] [Abstract][Full Text] [Related]
14. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476 [TBL] [Abstract][Full Text] [Related]
15. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease]. Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483 [No Abstract] [Full Text] [Related]
16. [The clinical characteristics of systemic sclerosis-related pulmonary arterial hypertension]. Wang H; Tian Z; Liu Y; Li M; Wang Q; Zeng X; Fang Q Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):390-3. PubMed ID: 25146407 [TBL] [Abstract][Full Text] [Related]
17. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes. Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Follicle-Stimulating Hormone Levels in Predicting Survival in Men With Idiopathic Pulmonary Arterial Hypertension. Wang Q; Sun YY; Huang YX; Wang L; Miao YQ; Yuan P Am J Mens Health; 2022; 16(1):15579883211067084. PubMed ID: 34979822 [TBL] [Abstract][Full Text] [Related]